Search Results

Looking for a specific product? Go to our product catalog

Showing 25 from 880 results

Top News December 11 2024

Top News November 25 2024

Top News November 21 2024

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate

Top News September 11 2024

Top News August 12 2024

Top News August 6 2024

Top News July 30 2024

Government Tour of Teva Canada’s Stouffville Manufacturing Facility Showcases Pharmaceutical Capabilities and Underscores Economic Value to Canada

Top News July 15 2024

Top News July 2 2024

New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

Top News June 27 2024

Top News June 14 2024

Top News June 13 2024

Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Top News June 4 2024

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
 
Click here for more information in WhatsApp message